Table 1. Clinical and laboratory characteristics.
| NP-COVID-19+ (n = 9–15)a | P-COVID-19+ (n = 8–15)b | P-COVID-19- (n = 13)c | p | |
|---|---|---|---|---|
| Age (years) | 34.1±7 | 28±7.1 | 25.6±5.7 | a vs. c 0.006 |
| BMI | 31.6±6.9 | 30.0±6.3 | 28.0±3.5 | 0.356 |
| Respiratory Rate (breaths per min) | 23±3.8 | 22.1±6.8 | 18.6±1.1 | a vs. c 0.005 |
| Heart Rate (beats per min) | 91.2±25.1 | 97.3±19.6 | 77.7±7.5 | b vs. c 0.048 |
| Temperature (°C) | 36.9±1.2 | 36.7±0.7 | 36.3±0.2 | 0.081 |
| Mean Arterial Pressure (mmHg) | 159.5±17.4 | 153.2±15.4 | 157.1±13.3 | 0.631 |
| Hemoglobin | 13±2.7 | 12.6±2.0 | 11.9±1.1 | 0.070 |
| Leucocytes (10xmm3) | 8.6±4 | 11.1±3.2 | 8.4±2.3 | 0.140 |
| NLR | 11.8±11.7 | 5.1±1.9 | 3.7±1.2 | a vs. c 0.009 |
| PLT (10xmm3) | 272.3±99.2 | 327.2±218.1 | 232.8±45.4 | 0.548 |
| Glucose (mg/dL) | 122.5±51.8 | 91.1±20.1 | 89.3±12.5 | 0.170 |
| Urea (mg/dL) | 30.9±20.4 | 17.4±5.7 | 18.3±5.9 | a vs. b 0.040 |
| a vs. c 0.027 | ||||
| Creatinine (mg/dL) | 0.7±0.3 | 1.0±1.1 | 0.5±0.2 | a vs. c 0.009 |
| LDH (U/L) | 804.9±1389 | 582.8±510.8 | 269.7±90.4 | b vs. c 0.005 |
| PT (seconds) | 15.2±3.3 | 11.5±1.1 | 11±0.4 | a vs. b 0.011 |
| a vs. c 0.0002 | ||||
| PTT (seconds) | 31.2±4.6 | 30.9±4 | 29.5±3.3 | 0.595 |
| D-Dimer (ng/mL) | 3.9±6.9 | 1513±1474 | 3215±1247 | a vs. b 0.028 |
| a vs. c <0.0001 | ||||
| Fibrinogen (mg/dL) | 662.7±167.5 | 693.9±186.3 | 566.2±103.4 | 0.195 |
| Oxygen saturation (%) | 88.4±13.3 | 91.1±5.6 | 98.5±0.5 | a vs. c 0.049 |
| Diabetes | 2 | 3 | 1 | 0.614 |
| Hypertension | 1 | 2 | 0 | 0.375 |
| Obesity | 5 | 6 | 0 | 0.037 |
| Gestational age (Weeks) | — | 31.4±5.7 | 35.3±4.8 | 0.069 |
| 2nd trimester | — | 2 | 1 | Ns |
| 3rd trimester | — | 13 | 12 | Ns |
Non-Pregnant COVID-19+ (NP-COVID-19+), Pregnant COVID-19+ (P-COVID-19+), Pregnant COVID-19- (P-COVID-19-). BMI; Body Mass Index. NLR; Neutrophil/Lymphocyte Ratio. Kruskal–Wallis test and Dunn’s multiple comparisons test. Significant p<0.05. Mean±SD.